## Background: Thiopurines are considered first-line immunomodulators for the prevention of relapse in moderate to severe pediatric crohn's disease (cd). early introduction of thiopurines was shown in a pediatric trial to maintain steroid-free remission in 90% of patients for 18 months. in the pres
Efficacy of methotrexate in pediatric Crohn's disease: A French multicenter study
✍ Scribed by S. Uhlen; R. Belbouab; K. Narebski; O. Goulet; J. Schmitz; J.P. Cézard; D. Turck; Dr. F.M. Ruemmele
- Book ID
- 110087437
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 179 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1078-0998
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: We evaluated adherence to adalimumab therapy in Crohn's disease (CD). Methods: This was an observational multicenter study conducted in four French university hospitals between April 4, 2008 and January 1, 2010. Patients were systematically asked, at each clinical visit, whether or not
## Background: Infliximab (ifx) is efficacious in inducing remission in severe forms of pediatric crohn's disease (cd). adult studies indicate that ifx is also safe and well tolerated as maintenance therapy. the present study aimed to evaluate in a prospective manner the efficacy and safety of ifx